Literature DB >> 21747630

Interferon-alpha Induced Sarcoidosis with Cutaneous Involvement along the Lines of Venous Drainage.

Young Bok Lee1, Jae In Lee, Hyun Jeong Park, Baik Kee Cho, Shin Taek Oh.   

Abstract

Sarcoidosis is a systemic inflammatory disease of an unknown origin and it is characterized by the presence of noncaseating epitheloid cell granulomas in multiple organs. Herein we report on a case of cutaneous and pulmonary sarcoidosis that was associated with interferon alpha treatment for hepatitis C. A 39-year-old man, a former intravenous drug user, presented with several erythematous papules on both antecubital areas. The histopathologic finding of a skin biopsy showed noncaseating granuloma. The mediastinal and axillary lymph nodes were enlarged on chest X-ray and computed tomography. To the best of our knowledge, this is the first report of cutaneous and pulmonary sarcoidosis that was associated with interferon treatment in the Korean dermatologic literature.

Entities:  

Keywords:  Hepatitis C; Interferon alpha; Intraveous drug user; Sarcoidosis; Scar

Year:  2011        PMID: 21747630      PMCID: PMC3130874          DOI: 10.5021/ad.2011.23.2.239

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  16 in total

Review 1.  Sarcoidosis.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki; Alvin S Teirstein
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

2.  HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications.

Authors:  Maria Rosaria Zampino; Monica Corazza; Alessandro Borghi; Andrea Marzola; Annarosa Virgili
Journal:  Acta Derm Venereol       Date:  2009-11       Impact factor: 4.437

Review 3.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

4.  Sarcoidosis and hepatitis C: clinical description of 11 cases.

Authors:  Pierre Faurie; Christiane Broussolle; Fabien Zoulim; Christian Trepo; Pascal Sève
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-08       Impact factor: 2.566

Review 5.  Extrahepatic manifestations in patients with chronic hepatitis C virus infection.

Authors:  Manuel Ramos-Casals; Josep Font
Journal:  Curr Opin Rheumatol       Date:  2005-07       Impact factor: 5.006

Review 6.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 7.  Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.

Authors:  Eva A Hurst; Theodora Mauro
Journal:  Arch Dermatol       Date:  2005-07

Review 8.  Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases.

Authors:  Manuel Ramos-Casals; Juan Mañá; Norma Nardi; Pilar Brito-Zerón; Antoni Xaubet; José Maria Sánchez-Tapias; Ricard Cervera; Josep Font
Journal:  Medicine (Baltimore)       Date:  2005-03       Impact factor: 1.889

9.  Sarcoidosis and interferon therapy: report of five cases and review of the literature.

Authors:  Stéphanie Leclerc; Robert P. Myers; Joseph Moussalli; Serge Herson; Thierry Poynard; Olivier Benveniste
Journal:  Eur J Intern Med       Date:  2003-07       Impact factor: 4.487

10.  Association between IFNA genotype and the risk of sarcoidosis.

Authors:  Mitsuteru Akahoshi; Mami Ishihara; Natascha Remus; Kazuko Uno; Katsuhisa Miyake; Tomomitsu Hirota; Kazuko Nakashima; Akira Matsuda; Mizuo Kanda; Tadao Enomoto; Shigeaki Ohno; Hitoshi Nakashima; Jean-Laurent Casanova; Julian M Hopkin; Mayumi Tamari; Xiao-Quan Mao; Taro Shirakawa
Journal:  Hum Genet       Date:  2004-03-05       Impact factor: 4.132

View more
  3 in total

Review 1.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

2.  Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C.

Authors:  Remi Trien; Chad J Cooper; David Paez; Edgardo Colon; Shajeea Ajmal; Hasan Salameh
Journal:  Am J Case Rep       Date:  2014-05-28

3.  A Case of Subcutaneous Sarcoidosis Occurring along the Superficial Veins of the Forearms: A Distinctive Cutaneous Manifestation Masquerading Venous Tropic Action in the Underlying Systemic Disease?

Authors:  Haruka Koizumi; Noritaka Oyama; Yukinori Hayakawa; Minoru Hasegawa
Journal:  Case Rep Dermatol       Date:  2017-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.